Company Filing History:
1 out of 35 
1 out of 243 
Years Active: 2018
Title: Anja Nickstadt: Innovator in Cancer Vaccine Development
Introduction
Anja Nickstadt is a prominent inventor based in Halle, Germany. She has made significant contributions to the field of cancer research, particularly in the development of innovative vaccines. Her work focuses on harnessing the immune system to combat cancer effectively.
Latest Patents
Anja Nickstadt holds a patent for a HER2/Neu cancer vaccine. This patent, which includes a protein conjugate comprising a protein antigen for generating an immune response against the HER2/neu protein, represents a crucial advancement in cancer treatment. The immunogenic carrier is covalently bonded to the protein antigen, enhancing the vaccine's efficacy.
Career Highlights
Throughout her career, Anja has worked with notable organizations, including Icon Genetics GmbH and the University of Southampton. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Anja has collaborated with talented individuals such as Natalia Savelyeva and Franziska Jarczowski. These partnerships have enriched her research and expanded the impact of her innovations in cancer treatment.
Conclusion
Anja Nickstadt's work in developing a HER2/Neu cancer vaccine showcases her dedication to advancing medical science. Her contributions are vital in the ongoing fight against cancer, and her innovative spirit continues to inspire future research.